Donitriptan
CAS No. 170912-52-4
Donitriptan( —— )
Catalog No. M26168 CAS No. 170912-52-4
Donitriptan is a 5-HT receptor agonist with pKis of 9.4 and 9.3 for 5-HT1B and 5-HT1D, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 67 | Get Quote |
|
5MG | 110 | Get Quote |
|
10MG | 178 | Get Quote |
|
25MG | 410 | Get Quote |
|
50MG | 605 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDonitriptan
-
NoteResearch use only, not for human use.
-
Brief DescriptionDonitriptan is a 5-HT receptor agonist with pKis of 9.4 and 9.3 for 5-HT1B and 5-HT1D, respectively.
-
DescriptionDonitriptan is a 5-HT receptor agonist with pKis of 9.4 and 9.3 for 5-HT1B and 5-HT1D, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorCOX-2| granzyme B| IL-1β| MCP-1| TNF-α| VEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number170912-52-4
-
Formula Weight403.486
-
Molecular FormulaC23H25N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (619.61 mM)
-
SMILESNCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c3ccc(cc3)C#N)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang WH, et al. Lupeol acetate ameliorates collagen-induced arthritis and osteoclastogenesis of mice through improvement of microenvironment. Biomed Pharmacother. 2016;79:231-240.
molnova catalog
related products
-
Mianserin hydrochlor...
Mianserin hydrochloride is a H1 receptor inverse agonist and is a psychoactive agent of the tetracyclic antidepressant.
-
Zolmitriptan
Zolmitriptan is a selective serotonin receptor agonist.
-
Vortioxetine
Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.